Home > Drug Search >
  • company_query: Areva Pharmaceuticals
  •   > 
Drug Filter
Category:
chemistry (55) biology (14)
Status:
Approved (3) NDA Filing (1) BLA Filing (1) Phase Ⅲ (8) Phase Ⅱ (28) Phase Ⅰ (27) IND Filing (1)
Clinical Stage:
Pending (13) Active (32) Discontinued (21)
Bio-Type:
Coagulation factor (2) Gene therapy (1) Cell therapy (1) Vaccine (1) Recombinant cytokines (1) Recombinant hormone (1) Whole antibody (3)
Indication:
Acne (1) Actinic keratosis (AK) (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (3) Angina pectoris (1) Arrhythmia (1) Cerebral infarction (1) Chemotherapy-induced nausea and vomiting (1) Chronic lymphocytic leukemia (CLL) (2) Chronic myeloid leukemia (CML ) (1) Cutaneous T cell lymphoma (CTCL) (1) Depression (1) Dry eye disease (1) Duchenne muscular dystrophy (DMD) (3) Dyslipidemia (1) Epidermolysis bullosa (1) Erectile dysfunction (ED) (1) Gastric cancer (1) Growth hormone deficit (1) HCV infection (3) Hepatocellular carcinoma (HCC) (1) HIV infection (2) Hypertension (2) Leiomyoma (1) Leukemia (2) Lung cancer (1) Melanoma (1) Metastatic melanoma (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (4) Obesity (2) Ovarian cancer (1) Overactive bladder (OAB) (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Postherpetic neuralgia (PHN) (1) Mucopolysaccharidosis III (2) Renal cell carcinoma (2) Rheumatoid arthritis (RA) (1) Secondary hyperparathyroidism (HPT) (1) Social withdrawal (1) Solid tumours (10) Marburg virus disease (2) Tuberculosis (1) Type 2 diabetes (2) Head and neck cancer (3) Influenza A virus infections (1) Colorectal cancer (1) Fallopian tube cancer (1) Susceptible bacterial infections (1) Malignant glioma (1) Biliary cancer (1) Diabetes (1) Hemophilia B (1) Hematological cancer (2) Hyperphosphatemia (1) Growth failure (1) Sepsis (1) Ischemic stroke (1) Neurotrophic Keratitis (NK) (1) Glioblastoma (1) Graft versus host disease (1) Metastatic cancer (1) West nile virus infection (1) Mesothelioma (1) Brain cancer (1) Lipodystrophy (1) Liver cancer (1) Pharmaceutical aids (1) Coronary restenosis (1) Thromboembolism (1) hematological malignancies (1) Ebola virus disease (EVD) (2) Cartilage and bone regeneration (1) Inflammation (1) Hemophilia (1)
Country:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 4 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top